1.

Effect of the Biological Drug Etanercept on Tumor necrosis factor-α Levels in Psoriatic Patients

Volume 59, Issue 2, June 2018, Pages 998-1005
Basman Medhat Fadheel; Ban Noori Al-Qadhi; Rasha Hussain Kuba
2.

Effects of Methotrexate and Etanercept on C-Reactive Protein and Anti-Cyclic Citrullinated Peptide Antibodies level In Rheumatoid Arthritis Patients

Volume 0, Issue 0, March 2017, Pages 120-124
Khawla H. Zhair; Rasha Hussain Kuba; Yasser abdulhussain Jafar
3.

Efficacy of Etanercept Treatment in Iraqi Patients with Moderate to Severe Psoriasis

Volume 19, Issue 1, March 2020, Pages 9-15
Ihsan Al-Turfy; Shahad Abdulmunaf Hamza
4.

Etanercept ameliorate cardiac damage and Apoptosis Induced by Myocardial Ischemia/Reperfusion in male mice.

Volume 5, Issue 2, December 2014, Pages 105-118
Najah R. Hadi; Fadhil G. Yousif; Maitham G Yousif; Saif M. Hassan
5.

Gene Expression and Polymorphism of Interleukin-4 in a Sample of Iraqi Rheumatoid Arthritis Patients

Volume 15, Issue 2, December 2018, Pages 130-137
hiah; Ali H. Ad; Aseel S. Mahmood; Abdul-Kareem A. Al-Kazaz; Khadier K. Mayouf
6.

The impact of understanding the difference in response of TNFa and CXCL13 in patients with rheumatoid arthritis and ankylosing spondylitis concerning treatment strategy of both diseases

Volume 40, Issue 1, June 2022, Pages 51-60
saif ali jabbar salman aljubran; Nabeel Abduljaleel Ali; Jawad Hasan Ahmed; saad wahid


Journal Management System. Powered by ejournalplus.com